These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8710157)

  • 1. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.
    Locatelli F; Marcelli D; Comelli M; Alberti D; Graziani G; Buccianti G; Redaelli B; Giangrande A
    Nephrol Dial Transplant; 1996 Mar; 11(3):461-7. PubMed ID: 8710157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.
    Yoshida T; Takei T; Shirota S; Tsukada M; Sugiura H; Itabashi M; Ogawa T; Uchida K; Tsuchiya K; Nitta K
    Intern Med; 2008; 47(21):1859-64. PubMed ID: 18981628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of dietary intake and serum lipids interact with proteinuria as risk factors for progression of chronic renal failure.
    Boaz M; Biro A; Katzir Z; Smetana S
    Ren Fail; 1998 Mar; 20(2):383-90. PubMed ID: 9574466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group.
    Locatelli F; Alberti D; Graziani G; Buccianti G; Redaelli B; Giangrande A; Marcelli D; Francucci BM
    Miner Electrolyte Metab; 1992; 18(2-5):295-302. PubMed ID: 1465079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidaemia and the progression of renal disease in chronic renal failure patients.
    Massy ZA; Nguyen Khoa T; Lacour B; Descamps-Latscha B; Man NK; Jungers P
    Nephrol Dial Transplant; 1999 Oct; 14(10):2392-7. PubMed ID: 10528663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.
    Jungers P; Hannedouche T; Itakura Y; Albouze G; Descamps-Latscha B; Man NK
    Nephrol Dial Transplant; 1995; 10(8):1353-60. PubMed ID: 8538926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of the non-nephrotic membranous nephropathy patient.
    Hladunewich MA; Troyanov S; Calafati J; Cattran DC;
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1417-22. PubMed ID: 19661220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study.
    Liang S; Le W; Liang D; Chen H; Xu F; Chen H; Liu Z; Zeng C
    BMC Nephrol; 2016 Apr; 17():42. PubMed ID: 27066888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P; Perna A; Mosconi L; Matalone M; Pisoni R; Gaspari F; Remuzzi G
    Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria.
    Syme HM; Markwell PJ; Pfeiffer D; Elliott J
    J Vet Intern Med; 2006; 20(3):528-35. PubMed ID: 16734085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of renal failure in chronic primary glomerular diseases.
    Gonzalo A; Gallego A; Rivera M; Gallego N; Ortuño J
    Nephron; 1994; 68(1):32-7. PubMed ID: 7991038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.